Cargando…
Novel loss-of-function variants in TRIO are associated with neurodevelopmental disorder: case report
BACKGROUND: Damaging variants in TRIO have been associated with moderate to severe neurodevelopmental disorders in humans. While recent work has delineated the positional effect of missense variation on the resulting phenotype, the clinical spectrum associated with loss-of-function variation has yet...
Autores principales: | Schultz-Rogers, Laura, Muthusamy, Karthik, Pinto e Vairo, Filippo, Klee, Eric W., Lanpher, Brendan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654171/ https://www.ncbi.nlm.nih.gov/pubmed/33167890 http://dx.doi.org/10.1186/s12881-020-01159-y |
Ejemplares similares
-
Haploinsufficiency as a disease mechanism in GNB1‐associated neurodevelopmental disorder
por: Schultz‐Rogers, Laura, et al.
Publicado: (2020) -
Analysis of trio test in neurodevelopmental disorders
por: Kim, Se Hee, et al.
Publicado: (2022) -
Novel de novo variant in EBF3 is likely to impact DNA binding in a patient with a neurodevelopmental disorder and expanded phenotypes: patient report, in silico functional assessment, and review of published cases
por: Blackburn, Patrick R., et al.
Publicado: (2017) -
Autoinhibition of the GEF activity of cytoskeletal regulatory protein Trio is disrupted in neurodevelopmental disorder-related genetic variants
por: Bircher, Josie E., et al.
Publicado: (2022) -
Diagnostic Yields of Trio-WES Accompanied by CNVseq for Rare Neurodevelopmental Disorders
por: Gao, Chao, et al.
Publicado: (2019)